AR049518A1 - Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados - Google Patents
Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizadosInfo
- Publication number
- AR049518A1 AR049518A1 ARP050102466A ARP050102466A AR049518A1 AR 049518 A1 AR049518 A1 AR 049518A1 AR P050102466 A ARP050102466 A AR P050102466A AR P050102466 A ARP050102466 A AR P050102466A AR 049518 A1 AR049518 A1 AR 049518A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- composition including
- active principles
- silicone agent
- solubilized active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composicion farmacéutica estable, anhidra, que comprende un agente siliconado que comprende, al menos, un elastomero organopoli-siloxano y a título de principios activos, vitamina D o un derivado de la vitamina D y un corticosteroide, a su procedimiento de preparacion, y a su utilizacion para el tratamiento topico de la psoriasis y otras afecciones cutáneas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0406610A FR2871695B1 (fr) | 2004-06-17 | 2004-06-17 | Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049518A1 true AR049518A1 (es) | 2006-08-09 |
Family
ID=34948706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102466A AR049518A1 (es) | 2004-06-17 | 2005-06-16 | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados |
Country Status (7)
Country | Link |
---|---|
US (1) | US7901698B2 (es) |
CN (1) | CN1968701A (es) |
AR (1) | AR049518A1 (es) |
FR (1) | FR2871695B1 (es) |
MX (1) | MXPA06014300A (es) |
RU (1) | RU2007101511A (es) |
ZA (1) | ZA200700304B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
CA2611147C (en) | 2005-06-01 | 2013-04-09 | Stiefel Research Australia Pty Ltd. | Topical emulsion formulation |
US20080153786A1 (en) * | 2006-05-22 | 2008-06-26 | Galderma S.A. | Controlled release of drugs into/through the skin |
FR2887150B1 (fr) * | 2005-06-17 | 2007-08-03 | Galderma Res & Dev | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise |
WO2008065514A2 (en) * | 2006-11-29 | 2008-06-05 | Glenmark Pharmaceuticals Limited | Pharmaceutical compositions containing anhydrous calcipotriene |
EP1970048A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D |
US10265265B2 (en) * | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
WO2008131267A2 (en) * | 2007-04-18 | 2008-10-30 | Johns Hopkins University | Low calcemic, highly antiproliferative, analogs of calcitriol |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
US20090175810A1 (en) * | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
CN108273065B (zh) | 2011-03-14 | 2020-07-31 | 药品配送方案有限公司 | 一种眼用组合物 |
CA2834301A1 (en) * | 2011-05-02 | 2012-11-08 | Lipidor Ab | Treatment of psoriasis |
WO2013094683A1 (ja) * | 2011-12-21 | 2013-06-27 | マルホ株式会社 | シリコーン基剤を含有する皮膚用組成物 |
US20140107223A1 (en) * | 2012-10-12 | 2014-04-17 | Whitehill Oral Technologies, Inc. | Topical ubiquinol supplement skin care compositions |
TWI503279B (zh) * | 2013-01-09 | 2015-10-11 | Univ Nat Cheng Kung | Silica gel composition and preparation method thereof |
BR112018005200A2 (pt) | 2015-09-16 | 2018-10-09 | Dfb Soria Llc | liberação de nanopartículas de fármaco e métodos de uso dos mesmos |
US20180000836A1 (en) * | 2016-07-01 | 2018-01-04 | Yousif Kattoula | Topical Treatment for Psoriasis |
EP3595633B1 (en) | 2017-03-15 | 2023-07-05 | DFB Soria, LLC | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
CA3092500A1 (en) | 2018-03-16 | 2019-09-19 | Dfb Soria, Llc | Topical therapy for the treatment of cervical intraepithelial neoplasia (cin) and cervical cancer using nanoparticles of taxanes |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
US20210346471A1 (en) * | 2020-04-30 | 2021-11-11 | Danny C Purser | Superoxide dismutase compositions and methods |
RU2742411C1 (ru) * | 2020-10-08 | 2021-02-05 | Георгий Сергеевич Немов | Противопсориатическая косметическая композиция в виде геля |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4308264A (en) * | 1981-01-28 | 1981-12-29 | Abbott Laboratories | Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration |
US4678663A (en) * | 1984-02-06 | 1987-07-07 | Nuetrogena Corporation | Hydroquinone composition having enhanced bio-availability and percutaneous adsorption |
US5254334A (en) * | 1992-05-04 | 1993-10-19 | Imaginative Research Associates, Inc. | Anhydrous foaming composition containing low concentrations of detergents and high levels of glycerin amd emollients such as oils and esters |
FR2719220A1 (fr) | 1994-04-29 | 1995-11-03 | Lafon Labor | Nouvelle forme galénique pour l'administration transdermique. |
FR2737118B1 (fr) * | 1995-07-28 | 1997-09-05 | Oreal | Composition dermatologique ou pharmaceutique, procede de preparation et utilisation |
FR2738745B1 (fr) * | 1995-09-15 | 1997-10-24 | Cird Galderma | Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations |
IT1302275B1 (it) * | 1998-09-25 | 2000-09-05 | Giorgio Panin | Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica. |
MXPA01010676A (es) * | 1999-04-23 | 2003-08-20 | Leo Pharm Prod Ltd | Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide. |
DE10024413A1 (de) * | 2000-05-19 | 2001-12-06 | Mika Pharma Gmbh | Pharmazeutische und/oder kosmetische Zubereitung |
US20020018791A1 (en) * | 2000-07-10 | 2002-02-14 | Vatter Michael Lee | Anhydrous cosmetic compositions |
US20030091522A1 (en) * | 2001-08-24 | 2003-05-15 | Collins Carol J. | Reduced-wax mascara compositions |
US20070190124A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
-
2004
- 2004-06-17 FR FR0406610A patent/FR2871695B1/fr not_active Expired - Fee Related
- 2004-09-29 US US10/951,887 patent/US7901698B2/en not_active Expired - Fee Related
-
2005
- 2005-06-15 CN CNA200580019989XA patent/CN1968701A/zh active Pending
- 2005-06-15 RU RU2007101511/15A patent/RU2007101511A/ru unknown
- 2005-06-15 MX MXPA06014300A patent/MXPA06014300A/es not_active Application Discontinuation
- 2005-06-16 AR ARP050102466A patent/AR049518A1/es unknown
-
2007
- 2007-01-11 ZA ZA200700304A patent/ZA200700304B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1968701A (zh) | 2007-05-23 |
US20050282788A1 (en) | 2005-12-22 |
MXPA06014300A (es) | 2007-02-19 |
FR2871695A1 (fr) | 2005-12-23 |
ZA200700304B (en) | 2007-12-27 |
FR2871695B1 (fr) | 2008-07-04 |
RU2007101511A (ru) | 2008-07-27 |
US7901698B2 (en) | 2011-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
EA200702204A1 (ru) | Лечение заболеваний соединительной ткани кожи | |
CU23423B7 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea | |
GT200900154A (es) | Derivados de 2,3-dihidroimidozo [1,2-c] quinizolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
BR112012018500A2 (pt) | alguns inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso destas | |
AR049985A1 (es) | Tratamiento de combinacion para enfermedades malignas no hematologicas | |
BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
BRPI0507198A (pt) | derivados de bisariluréia | |
CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
ATE332136T1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
NO20061236L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton | |
BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
MX2009011900A (es) | Curacion de herida diabetica. | |
BR112012015433A2 (pt) | composição farmacêutica substancialmente anidra para aplicação cutânea | |
FR2887150B1 (fr) | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise | |
BRPI0511398A (pt) | composição farmacêutica anidra para o tratamento da psorìase e uso de um agente siliconado | |
AR045783A1 (es) | Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide | |
SE0950392L (sv) | Sammansättning för behandling av hudåkommor | |
BR112021017957A2 (pt) | Derivado tienoeterocíclico, método de preparação do mesmo e uso médico do mesmo | |
BRPI0607976A2 (pt) | composição farmacêutica e uso de uma composição | |
WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
AR046146A1 (es) | Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |